Advertisement

Depressive symptoms and risk of uterine leiomyomata

Published:December 13, 2014DOI:https://doi.org/10.1016/j.ajog.2014.12.012

      Objective

      Uterine leiomyomata (UL) are a major source of gynecologic morbidity and the primary indication for hysterectomy. Depression can cause dysregulation of the hypothalamic-pituitary-adrenal axis, which may affect the synthesis of reproductive hormones involved in UL pathogenesis. We assessed the association between depressive symptoms and UL among 15,963 premenopausal women.

      Study Design

      Data were derived from the Black Women’s Health Study, a prospective cohort study. In 1999 and 2005, the Center for Epidemiologic Studies Depression Scale (CES-D) was used to ascertain depressive symptoms. On biennial follow-up questionnaires from 1999 through 2011, women reported physician-diagnosed depression, antidepressant use, and UL diagnoses. Incidence rate ratios (IRRs) and 95% confidence intervals (CIs) were estimated using multivariable Cox regression.

      Results

      There were 4722 incident UL cases diagnosed by ultrasound (n = 3793) or surgery (n = 929) during 131,262 person-years of follow-up. Relative to baseline CES-D scores <16, IRRs were 1.05 (95% CI, 0.98–1.13) for CES-D scores 16-24 and 1.16 (95% CI, 1.06–1.27) for CES-D scores ≥25 (P-trend = .001). IRRs for current and past physician-diagnosed depression relative to no depression were 1.15 (95% CI, 0.98–1.34) and 1.25 (95% CI, 1.13–1.39), respectively. Results persisted after further control for antidepressant use. IRRs for current and past use of antidepressants (any indication) relative to never use were 1.11 (95% CI, 0.97–1.28) and 1.32 (95% CI, 1.14–1.52), respectively.

      Conclusion

      In this cohort of black women, greater depressive symptoms were associated with UL, independent of antidepressant use, supporting the hypothesis that dysregulation of the hypothalamic-pituitary-adrenal axis increases UL risk.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Stewart E.A.
        Uterine fibroids.
        Lancet. 2001; 357: 293-298
        • Baird D.D.
        • Dunson D.B.
        • Hill M.C.
        • Cousins D.
        • Schectman J.M.
        High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence.
        Am J Obstet Gynecol. 2003; 188: 100-107
        • Whiteman M.K.
        • Kuklina E.
        • Jamieson D.J.
        • Hillis S.D.
        • Marchbanks P.A.
        Inpatient hospitalization for gynecologic disorders in the United States.
        Am J Obstet Gynecol. 2010; 202: 541.e1-541.e6
        • Cardozo E.R.
        • Clark A.D.
        • Banks N.K.
        • Henne M.B.
        • Stegmann B.J.
        • Segars J.H.
        The estimated annual cost of uterine leiomyomata in the United States.
        Am J Obstet Gynecol. 2012; 206: 211.e1-211.e9
        • Wise L.A.
        • Laughlin-Tommaso S.K.
        Uterine leiomyomata.
        in: Goldman M.B. Troisi R. Rexrode K.M. Women and health. 2nd ed. Academic Press, San Diego, CA2013: 285-306
        • Rein M.S.
        • Nowak R.A.
        Biology of uterine myomas and myometrium in vitro.
        Semin Reprod Endocrinol. 1992; 10: 310-319
        • Rein M.S.
        • Barbieri R.L.
        • Friedman A.J.
        Progesterone: a critical role in the pathogenesis of uterine myomas.
        Am J Obstet Gynecol. 1995; 172: 14-18
        • Baird D.
        • Wise L.A.
        Childhood abuse and fibroids.
        Epidemiology. 2011; 22: 15-17
        • Vines A.I.
        • Ta M.
        • Esserman D.A.
        The association between self-reported major life events and the presence of uterine fibroids.
        Womens Health Issues. 2010; 20: 294-298
        • Wise L.A.
        • Palmer J.R.
        • Cozier Y.C.
        • Hunt M.O.
        • Stewart E.A.
        • Rosenberg L.
        Perceived racial discrimination and risk of uterine leiomyomata.
        Epidemiology. 2007; 18: 747-757
        • Boynton-Jarrett R.
        • Rich-Edwards J.W.
        • Jun H.-J.
        • Hibert E.N.
        • Wright R.J.
        Abuse in childhood and risk of uterine leiomyoma: the role of emotional support in biologic resilience.
        Epidemiology. 2011; 22: 6-14
        • Wise L.A.
        • Palmer J.R.
        • Rosenberg L.
        Lifetime abuse victimization and risk of uterine leiomyomata in black women.
        Am J Obstet Gynecol. 2013; 208: 272.e1-272.e13
        • US Burden of Disease Collaborators
        The state of US health, 1990-2010: burden of diseases, injuries, and risk factors.
        JAMA. 2013; 310: 591-608
        • Ferrari A.J.
        • Somerville A.J.
        • Baxter A.J.
        • et al.
        Global variation in the prevalence and incidence of major depressive disorder: a systematic review of the epidemiological literature.
        Psychol Med. 2013; 43: 471-481
        • Jones-Webb R.J.
        • Snowden L.R.
        Symptoms of depression among blacks and whites.
        Am J Public Health. 1993; 83: 240-244
        • Miller D.K.
        • Malmstrom T.K.
        • Joshi S.
        • Andresen E.M.
        • Morley J.E.
        • Wolinsky F.D.
        Clinically relevant levels of depressive symptoms in community-dwelling middle-aged African Americans.
        J Am Geriatr Soc. 2004; 52: 741-748
        • Bromberger J.T.
        • Harlow S.
        • Avis N.
        • Kravitz H.M.
        • Cordal A.
        Racial/ethnic differences in the prevalence of depressive symptoms among middle-aged women: the study of Women's Health Across the Nation (SWAN).
        Am J Public Health. 2004; 94: 1378-1385
        • Somervell P.D.
        • Leaf P.J.
        • Weissman M.M.
        • Blazer D.G.
        • Bruce M.L.
        The prevalence of major depression in black and white adults in five United States communities.
        Am J Epidemiol. 1989; 130: 725-735
        • Berkman L.F.
        • Berkman C.S.
        • Kasl S.
        • et al.
        Depressive symptoms in relation to physical health and functioning in the elderly.
        Am J Epidemiol. 1986; 124: 372-388
        • Murrell S.A.
        • Himmelfarb S.
        • Wright K.
        Prevalence of depression and its correlates in older adults.
        Am J Epidemiol. 1983; 117: 173-185
        • Harman J.S.
        • Edlund M.J.
        • Fortney J.C.
        Disparities in the adequacy of depression treatment in the United States.
        Psychiatr Serv. 2004; 55: 1379-1385
        • Simpson S.M.
        • Krishnan L.L.
        • Kunik M.E.
        • Ruiz P.
        Racial disparities in diagnosis and treatment of depression: a literature review.
        Psychiatr Q. 2007; 78: 3-14
        • Plotsky P.M.
        • Owens M.J.
        • Nemeroff C.B.
        Psychoneuroendocrinology of depression: hypothalamic-pituitary-adrenal axis.
        Psychiatr Clin North Am. 1998; 21: 293-307
        • Young E.A.
        • Korszun A.
        The hypothalamic-pituitary-gonadal axis in mood disorders.
        Endocrinol Metab Clin North Am. 2002; 31: 63-78
        • Holsen L.M.
        • Lancaster K.
        • Klibanski A.
        • et al.
        HPA-axis hormone modulation of stress response circuitry activity in women with remitted major depression.
        Neuroscience. 2013; 250: 733-742
        • Carroll B.J.
        • Curtis G.C.
        • Davies B.M.
        • Mendels J.
        • Sugerman A.A.
        Urinary free cortisol excretion in depression.
        Psychol Med. 1976; 6: 43-50
        • Kronfol Z.
        • House J.D.
        • Silva Jr., J.
        • Greden J.
        • Carroll B.J.
        Depression, urinary free cortisol excretion and lymphocyte function.
        Br J Psychiatry. 1986; 148: 70-73
        • Carroll B.J.
        • Curtis G.C.
        • Mendels J.
        Cerebrospinal fluid and plasma free cortisol concentrations in depression.
        Psychol Med. 1976; 6: 235-244
        • Burke H.M.
        • Davis M.C.
        • Otte C.
        • Mohr D.C.
        Depression and cortisol responses to psychological stress: a meta-analysis.
        Psychoneuroendocrinology. 2005; 30: 846-856
        • Young A.H.
        • Gallagher P.
        • Porter R.J.
        Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients.
        Am J Psychiatry. 2002; 159: 1237-1239
        • Kam K.
        • Park Y.
        • Cheon M.
        • Son G.H.
        • Kim K.
        • Ryu K.
        Effects of immobilization stress on estrogen-induced surges of luteinizing hormone and prolactin in ovariectomized rats.
        Endocrine. 2000; 12: 279-287
        • Tilbrook A.J.
        • Canny B.J.
        • Serapiglia M.D.
        • Ambrose T.J.
        • Clarke I.J.
        Suppression of the secretion of luteinizing hormone due to isolation/restraint stress in gonadectomized rams and ewes is influenced by sex steroids.
        J Endocrinol. 1999; 160: 469-481
        • Breen K.M.
        • Billings H.J.
        • Wagenmaker E.R.
        • Wessinger E.W.
        • Karsch F.J.
        Endocrine basis for disruptive effects of cortisol on preovulatory events.
        Endocrinology. 2005; 146: 2107-2115
        • Holsen L.M.
        • Spaeth S.B.
        • Lee J.H.
        • et al.
        Stress response circuitry hypoactivation related to hormonal dysfunction in women with major depression.
        J Affect Disord. 2011; 131: 379-387
        • Holsen L.M.
        • Lee J.H.
        • Spaeth S.B.
        • et al.
        Brain hypoactivation, autonomic nervous system dysregulation, and gonadal hormones in depression: a preliminary study.
        Neurosci Lett. 2012; 514: 57-61
        • Rein M.S.
        Advances in uterine leiomyoma research: the progesterone hypothesis.
        Environ Health Perspect. 2000; 108: 791-793
        • Wise L.A.
        • Palmer J.R.
        • Harlow B.L.
        • et al.
        Risk of uterine leiomyomata in relation to tobacco, alcohol and caffeine consumption in the Black Women's Health Study.
        Hum Reprod. 2004; 19: 1746-1754
        • Wise L.A.
        • Radin R.G.
        • Palmer J.R.
        • Kumanyika S.K.
        • Boggs D.A.
        • Rosenberg L.
        Intake of fruit, vegetables, and carotenoids in relation to risk of uterine leiomyomata.
        Am J Clin Nutr. 2011; 94: 1620-1631
        • Wise L.A.
        • Radin R.G.
        • Palmer J.R.
        • Kumanyika S.K.
        • Rosenberg L.
        A prospective study of dairy intake and risk of uterine leiomyomata.
        Am J Epidemiol. 2010; 171: 221-232
        • Chiaffarino F.
        • Parazzini F.
        • La Vecchia C.
        • Chatenoud L.
        • Di Cintio E.
        • Marsico S.
        Diet and uterine myomas.
        Obstet Gynecol. 1999; 94: 395-398
        • Rosenberg L.
        • Adams-Campbell L.L.
        • Palmer J.R.
        The Black Women's Health Study: a follow-up study for causes and preventions of illness.
        J Am Med Womens Assoc. 1995; 50: 56-58
        • Radloff L.S.
        The CES-D scale: a self-report depression scale for research in the general population.
        Appl Psychol Measure. 1977; 1: 385-401
        • Kelley K.E.
        • Kelley T.P.
        • Kaufman D.W.
        • Mitchell A.A.
        The Slone Drug Dictionary: a research driven pharmacoepidemiology tool.
        Pharmacoepidemiol Drug Saf. 2003; 12: 168-169
        • Loutradis D.
        • Antsaklis A.
        • Creatsas G.
        • et al.
        The validity of gynecological ultrasonography.
        Gynecol Obstet Invest. 1990; 29: 47-50
        • Dueholm M.
        • Lundorf E.
        • Hansen E.S.
        • Ledertoug S.
        • Olesen F.
        Accuracy of magnetic resonance imaging and transvaginal ultrasonography in the diagnosis, mapping, and measurement of uterine myomas.
        Am J Obstet Gynecol. 2002; 186: 409-415
        • Myers E.R.
        • Bastian L.A.
        • Havrilesky L.J.
        • et al.
        Management of adnexal mass.
        Evid Rep Technol Assess (Full Rep). 2006; : 1-145
        • Jacobs Jr., D.R.
        • Ainsworth B.E.
        • Hartman T.J.
        • Leon A.S.
        A simultaneous evaluation of 10 commonly used physical activity questionnaires.
        Med Sci Sports Exerc. 1993; 25: 81-91
        • Carver C.S.
        You want to measure coping but your protocol's too long: consider the brief COPE.
        Int J Behav Med. 1997; 4: 92-100
        • Wise L.A.
        • Palmer J.R.
        • Stewart E.A.
        • Rosenberg L.
        Age-specific incidence rates for self-reported uterine leiomyomata in the Black Women's Health Study.
        Obstet Gynecol. 2005; 105: 563-568
        • Nguyen H.T.
        • Kitner-Triolo M.
        • Evans M.K.
        • Zonderman A.B.
        Factorial invariance of the CES-D in low socioeconomic status African Americans compared with a nationally representative sample.
        Psychiatry Res. 2004; 126: 177-187
        • Guarnaccia P.J.
        • Angel R.
        • Worobey J.L.
        The factor structure of the CES-D in the Hispanic Health and Nutrition Examination Survey: the influences of ethnicity, gender and language.
        Soc Sci Med. 1989; 29: 85-94
        • Roberts R.E.
        Reliability of the CES-D Scale in different ethnic contexts.
        Psychiatry Res. 1980; 2: 125-134
        • Callahan C.M.
        • Wolinsky F.D.
        The effects of gender and race on the measurement properties of the CES-D in older adults.
        Med Care. 1994; 32: 341-356
        • Williams C.D.
        • Taylor T.R.
        • Makambi K.
        • et al.
        CES-D four-factor structure is confirmed, but not invariant, in a large cohort of African American women.
        Psychiatry Res. 2007; 150: 173-180
        • Makambi K.H.
        • Williams C.D.
        • Taylor T.R.
        • Rosenberg L.
        • Adams-Campbell L.L.
        An assessment of the CES-D scale factor structure in black women: the Black Women's Health Study.
        Psychiatry Res. 2009; 168: 163-170
        • Harlow B.L.
        • Cohen L.S.
        • Otto M.W.
        • Spiegelman D.
        • Cramer D.W.
        Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles.
        Arch Gen Psychiatry. 1999; 56: 418-424
        • Wise L.A.
        • Adams-Campbell L.L.
        • Palmer J.R.
        • Rosenberg L.
        Leisure time physical activity in relation to depressive symptoms in the Black Women's Health Study.
        Ann Behav Med. 2006; 32: 68-76
        • Craig T.J.
        • Van Natta P.A.
        Presence and persistence of depressive symptoms in patient and community populations.
        Am J Psychiatry. 1976; 133: 1426-1429
        • Therneau T.M.
        • Grambsch P.M.
        Modeling survival data: extending the Cox model.
        Springer-Verlag, New York2000
        • Wise L.A.
        • Ruiz-Narváez E.A.
        • Palmer J.R.
        • et al.
        African ancestry and genetic risk for uterine leiomyomata.
        Am J Epidemiol. 2012; 176: 1159-1168
        • SAS Institute Inc
        SAS/STAT 9.4 user’s guide.
        SAS Institute, Cary, NC2014
        • Marshall L.M.
        • Spiegelman D.
        • Barbieri R.L.
        • et al.
        Variation in the incidence of uterine leiomyoma among premenopausal women by age and race.
        Obstet Gynecol. 1997; 90: 967-973
        • Brett K.M.
        • Marsh J.V.
        • Madans J.H.
        Epidemiology of hysterectomy in the United States: demographic and reproductive factors in a nationally representative sample.
        J Womens Health. 1997; 6: 309-316
        • Velebil P.
        • Wingo P.A.
        • Xia Z.
        • Wilcox L.S.
        • Peterson H.B.
        Rate of hospitalization for gynecologic disorders among reproductive-age women in the United States.
        Obstet Gynecol. 1995; 86: 764-769
        • Bromberger J.T.
        • Schott L.L.
        • Matthews K.A.
        • et al.
        Association of past and recent major depression and menstrual characteristics in midlife: Study of Women's Health Across the Nation.
        Menopause. 2012; 19: 959-966
        • Boyd J.H.
        • Weissman M.M.
        • Thompson W.D.
        • Myers J.K.
        Screening for depression in a community sample: understanding the discrepancies between depression symptom and diagnostic scales.
        Arch Gen Psychiatry. 1982; 39: 1195-1200
        • Abma J.C.
        • Chandra A.
        • Mosher W.D.
        • Peterson L.S.
        • Piccinino L.J.
        Fertility, family planning, and women's health: new data from the 1995 National Survey of Family Growth.
        Vital Health Stat. 1997; 23: 19
        • Harlow B.L.
        • Wise L.A.
        • Otto M.W.
        • Soares C.
        • Cohen L.S.
        Depression and its influence on reproductive endocrine and menstrual cycle markers associated with perimenopause: the Harvard Study of Moods and Cycles.
        Arch Gen Psychiatry. 2003; 60: 29-36
        • Scarinci I.C.
        • Beech B.M.
        • Naumann W.
        • Kovach K.W.
        • Pugh L.
        • Fapohunda B.
        Depression, socioeconomic status, age, and marital status in black women: a national study.
        Ethnicity and Disease. 2002; 12: 421-428